BDBM286449 6-(4-((3-(6-Chloropyridin-3-yl)-5-methoxybenzyl)oxy)-6-methoxybenzofuran-2-yl)-2-methoxyimidazo[2,1b][1,3,4]thiadiazole::US9518064, Example 66

SMILES COc1nn2cc(nc2s1)-c1cc2c(OCc3cc(OC)cc(c3)-c3ccc(Cl)nc3)cc(OC)cc2o1

InChI Key InChIKey=TVFXAXSHOKOXKP-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 286449   

TargetProteinase-activated receptor 4(Homo sapiens (Human))
Bristol-Myers Squibb

US Patent
LigandPNGBDBM286449(6-(4-((3-(6-Chloropyridin-3-yl)-5-methoxybenzyl)ox...)
Affinity DataIC50:  0.570nMT: 2°CAssay Description:The activity of the PAR4 antagonists of the present invention were tested in PAR4 expressing cells by monitoring H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-L...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent